Correction to: FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. . J Natl Cancer Inst 2025 May 30:djaf125. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. J Natl Cancer Inst 2025 May 30:djaf125. doi: 10.1093.
PMID: 40447274